Timothy S. Thorpe

Array ( [id] => 4129383 [patent_doc_number] => 06146837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Cyanidin compositions and therapeutic and diagnostic uses therefor' [patent_app_type] => 1 [patent_app_number] => 9/197683 [patent_app_country] => US [patent_app_date] => 1998-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 11963 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146837.pdf [firstpage_image] =>[orig_patent_app_number] => 197683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924506 [patent_doc_number] => 05952228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/059964 [patent_app_country] => US [patent_app_date] => 1998-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5131 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952228.pdf [firstpage_image] =>[orig_patent_app_number] => 059964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3932123 [patent_doc_number] => 05928938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Isolated peptides which complex with HLA-Cw*16 molecules, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/993738 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6438 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928938.pdf [firstpage_image] =>[orig_patent_app_number] => 993738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991807 [patent_doc_number] => 05919639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Ii peptide therapeutics to enhance antigen presentation' [patent_app_type] => 1 [patent_app_number] => 8/968676 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34561 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919639.pdf [firstpage_image] =>[orig_patent_app_number] => 968676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173461 [patent_doc_number] => 06140474 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Monoclonal antibody reactive with human-origin CETP and method of quantifying human-origin CETP' [patent_app_type] => 1 [patent_app_number] => 8/945646 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 20660 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140474.pdf [firstpage_image] =>[orig_patent_app_number] => 945646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126139 [patent_doc_number] => 06146630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Inhibitors for the adhesion of lymphocytes to glandular cells' [patent_app_type] => 1 [patent_app_number] => 8/946838 [patent_app_country] => US [patent_app_date] => 1997-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4065 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146630.pdf [firstpage_image] =>[orig_patent_app_number] => 946838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079883 [patent_doc_number] => 06054292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-25 [patent_title] => 'T-cell receptor protein' [patent_app_type] => 1 [patent_app_number] => 8/897097 [patent_app_country] => US [patent_app_date] => 1997-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20723 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/054/06054292.pdf [firstpage_image] =>[orig_patent_app_number] => 897097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4236926 [patent_doc_number] => 06075125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Production of antisera specific to major histocompatibility complex molecules in chickens' [patent_app_type] => 1 [patent_app_number] => 8/890719 [patent_app_country] => US [patent_app_date] => 1997-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17305 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075125.pdf [firstpage_image] =>[orig_patent_app_number] => 890719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4016342 [patent_doc_number] => 05880273 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Platelet activating factor acetylhydrolase, and gene thereof' [patent_app_type] => 1 [patent_app_number] => 8/886152 [patent_app_country] => US [patent_app_date] => 1997-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5878 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880273.pdf [firstpage_image] =>[orig_patent_app_number] => 886152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088280 [patent_doc_number] => 06025470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/880963 [patent_app_country] => US [patent_app_date] => 1997-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 7936 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025470.pdf [firstpage_image] =>[orig_patent_app_number] => 880963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781607 [patent_doc_number] => 05821125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Monoclonal antibody specific for novel PKA binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/865422 [patent_app_country] => US [patent_app_date] => 1997-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7109 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821125.pdf [firstpage_image] =>[orig_patent_app_number] => 865422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186543 [patent_doc_number] => 06042833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Cellular internalization of pIgR stalk and associated ligands' [patent_app_type] => 1 [patent_app_number] => 8/856383 [patent_app_country] => US [patent_app_date] => 1997-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10421 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042833.pdf [firstpage_image] =>[orig_patent_app_number] => 856383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185031 [patent_doc_number] => 06020477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1.beta. converting enzyme' [patent_app_type] => 1 [patent_app_number] => 8/776900 [patent_app_country] => US [patent_app_date] => 1997-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 14610 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020477.pdf [firstpage_image] =>[orig_patent_app_number] => 776900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3947645 [patent_doc_number] => 05955313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/842341 [patent_app_country] => US [patent_app_date] => 1997-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5111 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955313.pdf [firstpage_image] =>[orig_patent_app_number] => 842341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098640 [patent_doc_number] => 06051232 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Chimeric MHC class I antigens for inducing allograft tolerance' [patent_app_type] => 1 [patent_app_number] => 8/842656 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 26 [patent_no_of_words] => 10648 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051232.pdf [firstpage_image] =>[orig_patent_app_number] => 842656 [rel_patent_id] =>[rel_patent_doc_number] =>)